If you purchased or acquired securities in Merck between February 3, 2022 and February 3, 2025 and would like to discuss your ...
Fed Chair Powell discusses 2024's 2.5% GDP growth, easing inflation, rate cuts, regulation shifts, stablecoin oversight, and ...
Schrödinger faces financial losses amid investment in experimental drugs. Key 2025 trial results will reveal its future ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback